Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
about
Role of Sphingolipids in the Pathobiology of Lung InflammationPlausible Roles for RAGE in Conditions Exacerbated by Direct and Indirect (Secondhand) Smoke Exposure.Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma.Human lung and monocyte-derived macrophages differ with regard to the effects of β2-adrenoceptor agonists on cytokine releaseNovel aspects of pathogenesis and regeneration mechanisms in COPDResponsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls.Clinical characteristics of COPD patients with tidal expiratory flow limitation.COPD monocytes demonstrate impaired migratory abilityClinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.Protective role of γδ T cells in cigarette smoke and influenza infection.Human CCL3L1 copy number variation, gene expression, and the role of the CCL3L1-CCR5 axis in lung function.The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.Dysregulated Functions of Lung Macrophage Populations in COPD.Transcriptional Profiling of Immune-Related Genes in Leishmania infantum-Infected Mice: Identification of Potential Biomarkers of Infection and Progression of Disease.
P2860
Q26771956-06C312CD-A65E-495F-8437-A59C0BFE34F2Q30235227-CF5D4490-7370-49D3-A3B4-0D3DD5107297Q33569149-C3E7ADF0-87BE-404E-96E1-060E97164EFAQ33823753-715D9455-B254-4B01-B831-2A9B82A9791DQ35665638-FC3DA2EB-13D4-4EEE-8F9B-B06111B6DAAAQ36585746-1CD7C2F5-7219-4A30-B2DB-45993796C2D7Q40185581-CFE60C43-029D-46DC-B269-55362FB66FC5Q42079261-37D6CC43-994B-4FA1-A6D5-5B9D2A8DD082Q42358548-DE45706F-E65A-4EE8-99EF-F588F93E3F8CQ46748313-7FE48AC2-1C99-4EAD-B4A3-5264CE17A6D4Q52313026-0D509561-49FB-4758-A93A-2263F9AE05F6Q55177212-4092E136-B2F1-4053-8882-56E82C191C31Q55384969-C156290E-58C6-478C-8A98-7BC780119FB2Q55690609-09558AFE-7F37-4CFF-9C2B-33855F5F0BF1
P2860
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@ast
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@en
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@nl
type
label
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@ast
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@en
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@nl
prefLabel
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@ast
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@en
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.
@nl
P2093
P2860
P1433
P1476
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum
@en
P2093
Arjun K Ravi
Dave Singh
George Booth
Jonathan Lemon
Louise Healy
Matthew Catley
Shruti Khurana
P2860
P2888
P356
10.1186/PREACCEPT-2138593144993408
10.1186/S12931-014-0103-4
P577
2014-09-04T00:00:00Z
P5875
P6179
1028925841